1276 — Jiangsu Hengrui Pharmaceuticals Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapFalling Star

Market Cap
HK$449.01bn
Enterprise Value
HK$404.11bn
Revenue
CNY27.98bn

Annual balance sheet for Jiangsu Hengrui Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	16,359	18,697	17,871	20,845	25,076
Net Total Accounts Receivable
Net Total Receivables	9,277	7,659	9,050	6,681	6,422
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	28,050	30,188	30,934	31,287	35,315
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4,585	6,725	6,999	6,964	7,407
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	34,730	39,266	42,371	43,785	50,136
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,772	3,402	3,639	2,554	3,634
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	4,225	4,263	4,547	3,319	4,616
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	30,504	35,003	37,824	40,466	45,520
Total Liabilities & Shareholders' Equity	34,730	39,266	42,371	43,785	50,136
Total Common Shares Outstanding